The loss of enzymes responsible for BCAAs utilization, Bcat1 and Bcat2, impairs NSCLC tumor formation, although these enzymes are not essential for PDAC tumor formation (Li et al., 2020). This evidence concerns the gene BCAT1 and non-small cell lung carcinoma.